Johnson & Johnson posts higher sales, big 4Q profit jump
Higher prescription drug sales helped push Johnson & Johnson’s fourth-quarter profit up by 32%
Higher prescription drug sales helped push Johnson & Johnson’s fourth-quarter profit up by 32%.
The world’s biggest maker of health care products on Wednesday reported net income of $4.01 billion, or $1.50 per share. That’s up from $3.04 billion, or $1.12, a year earlier.
Adjusted earnings came to $1.88 per share, matching the expectations of industry analysts, according to a survey by FactSet.
Total revenue edged up 1.7% to $20.75 billion.
The New Brunswick, New Jersey, based maker of baby shampoo and biologic drugs forecast 2020 revenue of $85.4 billion to $86.2 billion, and adjusted earnings per share of $8.95 to $9.10.
How You Feel about this News,Post your comments and share the news..
(News are directly taken from Syndicate feeds,Press24 team not edited its content instead for title for more information visit source link)